1. A branched-chain 2-oxo acid dehydrogenase was partially purified from ox liver mitochondria. 2. The preparation oxidized 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and D-and L-3-methyl-2-oxopentanoate. The apparent Km values for the oxo acids and for thiamin pyrophosphate, CoA, NAD+ and Mg2+ were determined. 3. The oxidation of each oxo acid was inhibited by isovaleryl (3-methylbutyryl)-CoA (competitive with CoA) and by NADH (competitive with NAD+); K1 values were determined.
There is little information available about the properties and specificity of enzyme(s) catalysing the oxidative decarboxylation of the branched-chain 2-oxo acids formed by deamination of valine, leucine and isoleucine. Connelly et al. (1968) and described the partial purification and some properties of ox liver enzyme(s). Their evidence suggested the presence of two enzymes, which may catalyse reactions analogous to those of the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes. The Km values for 2-oxo acids were high (in the mm range) and they described inhibition by isovalerate (3-methylbutyrate). Wohlhueter & Harper (1970) have studied the decarboxylation of '4C-labelled branched-chain 2-oxo acids in extracts of rat liver. The apparent Km for 4-methyl-2-oxopentanoate was 0.2mm and their results suggested that a single enzyme may catalyse decarboxylation of all three branched-chain 2-oxo acids. Apart from this, lack of information about the relevant enzyme(s) contrasts with current interest in regulation of branched-chain amino acid metabolism and in the deficiency of branched-chain 2-oxo acid dehydrogenase activity in maple-syrup-urine disease.
We describe here kinetic properties and endproduct inhibition of branched-chain 2-oxo acid dehydrogenase activity partially purified from ox liver. We have been unable to purify the activity further. The main factors are low activity in tissues (relative Vol. 171 to that of pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase, which may be analogous enzyme complexes) and poor recovery (which is comparable with that achieved with pig heart pyruvate dehydrogenase complex in this laboratory). The problems (as with pyruvate dehydrogenase complex) were low yield of mitochondria in bulk preparations and loss ofactivity after removal ofmitochondrial membranes. However, by using two features that have been successful in preparing pyruvate dehydrogenase complex (use of digitonin to disrupt lysosomes before freezing and thawing of mitochondria, and centrifugation of active material on to a sucrose cushion) preparations have been obtained that could be reliably assayed by spectrophotometric methods based on NAD+ reduction.
Experimental

Materhals
The sodium salts of branched-chain 2-oxo acids 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and DL-3-methyl-2-oxopentanoate were obtained from Sigma (London) Chemical Co., Kingston upon Thames, Surrey, U.K. Solutions were assayed with branched-chain 2-oxo acid dehydrogenase complex (see under 'Methods'); the yields, as a fraction of the amount weighed, were: 0.75 (4-methyl-2-oxopentanoate); 0.91 (3-methyl-2-oxobutyrate); 
Methods
Preparation of isovaleryl-CoA. Isovaleryl chloride was prepared from isovaleric acid with PC13, and the fraction distilling at 114.5-115.5°C collected. Isovaleryl chloride was treated with an equimolar quantity of anhydrous sodium isovalerate to yield isovaleryl anhydride, which was collected by distillation at 212°C. Isovaleryl-CoA was synthesized from isovaleryl anhydride by the method described for the synthesis of acetyl-CoA by Simon & Shemin (1953) , but with a 1.5-fold excess of anhydride. The conversion of CoA into isovaleryl-CoA was 86 %. Isovaleryl-CoA was assayed as CoA released from isovaleryl-CoA by L-carnitine and carnitine acetyltransferase (Chase & Tubbs, 1965 (315g/litre) and, after stirring for 10min, the pellets were collected at 380000g-min. The pellets were resuspended in 120-150ml ofphosphate/EDTA buffer containing 1 mM-2-mercaptoethanol in a Teflon/glass Potter-Elvehjem homogenizer and dialysed overnight against 3 x 2 litres of the same buffer. The contents of the sac were adjusted to pH 6.1 with 10% (v/v) acetic acid and clarified by centrifugation for 5min at 38000g. The supernatant was adjusted to pH7.2 with KOH, shell-frozen and stored at -10°C for 4-5 days. The solution was then thawed, and the partially purified branched-chain 2-oxo acid dehydrogenase complex concentrated by centrifuging for 45min at 1500Og [9ml layered on to 0.5 ml of 60% (w/v) sucrose in phosphate/EDTA buffer containing 3 mM-dithiothreitol], and the top layer removed. The crude branched-chain 2-oxo acid dehydrogenase complex, which collected at the interface, was dissolved in the sucrose layer by sucking up and down in a Pasteur pipette. The solution of enzyme complex was stored at -10°C in 0.5ml or 1 ml samples.
The degree of purification achieved was only 25-fold compared with the supernatant after shellfreezing and thawing. The specific activity was only 1 munit/mg of protein.
[For protein estimation see Gornall et al. (1949) .] The preparations were stable for at least 2 months at -10°C. The yield of branchedchain 2-oxo acid dehydrogenase complex was approx. 2 units in 10ml. The preparations contained pyruvate dehydrogenase (approx. 4 units in 10ml), but were devoid of 2-oxoglutarate dehydrogenase.
Assay of branched-chain 2-oxo acid dehydrogenase complex. Spectrophotometric assay was based on NAD+ reduction followed at 340 nm. The assay buffer was 30mM-potassium phosphate, pH7.5, and the reaction was initiated (in 0.5ml volume) with 2-oxo acid. Other additions were as given in the text, Tables or Figures. One of the three preparations used showed NADH oxidase activity, which was suppressed with either rotenone (16,pg/ml) or 2-heptyl-4-hydroxyquinoline N-oxide (100,ug/ml). Rates of 1978 NAD+ reduction were proportional to added enzyme over the range used (2-8 munits/cuvette).
Radioactivity assay was based on "4CO2 production from 4-methyl-2-oxo[1 -14C]pentanoate. In this method incubations were made in glass liquidscintillation vials sealed with a serum stopper. The assay buffer was 30mM-potassium phosphate, pH7.5, with other additions as given in the text, Tables or Figures, in a total volume of 0.5 ml. The reaction was initiated by addition of enzyme. Incubations were made with shaking (45 cycles/min) at 300C for the time given and terminated by injection of 1001l of 50mM-glycine/HCI, pH 3.0. '4CO2 liberated over 90min was collected into 0.2ml of methanolic Hyamine hydroxide (10%, w/v) (in a small tube incorporated into the incubation vessel). Radioactivity in Hyamine was assayed by liquid-scintillation spectrometry by using a toluene-based scintillator (Severson et al., 1974) . Quench corrections were applied by means of an external standard.
Assay of 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and DL-3-methyl-2-oxopentanoate. These were assayed spectrophotometrically with branchedchain 2-oxo acid dehydrogenase complex by allowing NAD+ reduction to go to completion. This was achieved (in 30mM-potassium phosphate, pH7.5) with 1 mM-NAD+, 0.4mM-CoA, 0.4mM-thiamin pyrophosphate, 2mM-MgSO4, 1 mM-L-carnitine, 0.5 unit of carnitine acetyltransferase and 2munits of branchedchain 2-oxo acid dehydrogenase complex. The reaction took no more than 5 min to complete.
Expression of results. A unit of enzyme activity is the amount of enzyme catalysing the formation of 1 umol of product (NADH) in min at 30°C. In studies of enzyme kinetics Km and Vmax. were computed by the method of Jones (1970) . This method weights values at high substrate concentrations and yields unbiased values of Km and Vmax. by selecting a fit that gives least residual sum of squares in linear-regression analysis of the Lineweaver-Burk equation. Enzyme-inhibition data were analysed by fitting to the equation for mixed noncompetitive inhibition, and comparing the significAnce of fit (F-test) with that obtained by using the equations for competitive, simple linear non-competitive and uncompetitive inhibition (see Cleland, 1963a,b) .
Results and Discussion
It was found, by spectrophotometric assay, that the branched-chain 2-oxo acid dehydrogenase activity of these preparations required CoA, thiamin pyrophosphate and Mg2+ for NAD+ reduction. In determining apparent Km values for a reaction involving five substrates or cofactors (the above four plus 2-oxo acid), four have been fixed at concentrations not less than 10 times their apparent Km values.
Kinetics of oxidation of 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and DL-3-methyl-2-oxopentanoate by branched-chain 2-oxo acid dehydrogenase complex The apparent Km, values for 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and DL-3-methyl-2-oxopentanoate were determined in the range 0-200,uM (Table 1 ). All three observed Km values Table 1 . Substrate kinetics for branched-chain 2-oxo acid dehydrogenase complex ofox liver For details of enzyme preparation and spectrophotometric assay see the Experimental section. The variable concentrations in determination of apparent Km are shown in column 1. The non-variable concentrations were, as applicable: thiamin pyrophosphate, 0.4mM; NADI, 1 mM; MgSO4, 2mM; 2-oxo acid (as specified in parentheses), 0.15mM. Results are means±s.E.M.; the numbers in parentheses in column 2 are the numbers of individual rate measurements. The relative values for Vmax. are based on five rate measurements over a range of 10-100pM-2-Oxo acid.
Substrate (range of concns.) 4-Methyl-2-oxopentanoate (1-200,UM) 3-Methyl-2-oxobutyrate (1-14O0M) DL-3-Methyl-2-oxopentanoate (1-140uM) CoA (1-800,M) (4-methyl-2-oxopentanoate) CoA (37.5-400,UM) (3-methyl-2-oxobutyrate) CoA (3.1-400g,M) (DL-3-methyl-2-oxopentanoate) NAD+ (1O0M-S mM) (4-methyl-2-oxopentanoate) NAD+ (50gM-1 mM) (3-methyl-2-oxobutyrate) NAD+ (50gUM-1 mM) (DL-3-methyl-2-oxopentanoate) Thiamin pyrophosphate (0.4-80,UM) (4-methyl-2-oxopentanoate) Mg2+ (0.04-60,gM) (4-methyl-2-oxopentanoate) Apparent Km (uM) 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and DL-3-methyl-2-oxopentanoate. The value determined for DL-3-methyl-2-oxopentanoate is complex, since both the D and L forms were oxidized by these enzyme preparations (shown by 99.6 % conversion as assayed by NAD+ reduction). All three 2-oxo acids showed substrate inhibition at and above 500pum (Fig. 1) . The relative Vmax. values for the three 2-oxo acids, also determined in the range 0-200,uM, were 1.13:1.0:0.64 for 3-methyl-2-oxobutyrate, 4-methyl-2-oxopentanoate and DL-3-methyl-2-oxopentanoate respectively.
Apparent Branched-chain 2-oxo acid dehydrogenase complex was purified from ox liver and assayed spectrophotometrically (see under 'Methods'). The concentrations of the other substrates were: thiamin pyrophosphate, 0.4 mM; CoA, 0.4 mM; NAD+, 1 mM; MgSO4, 2 mM. Assays with this preparation were made in the presence of rotenone (16pg/ml) to suppress NADH oxidase activity. 1978 Table 2 . Inhibition by isovaleryl-CoA and NADHofbranched-chain 2-oxo acid dehydrogenase ofox liver See the Experimental section for details of enzyme preparation, spectrophotometric assay and isovaleryl-CoA preparation. Where applicable the fixed concentrations were: thiamin pyrophosphate, 0.4mM; CoA, 0.4mM; NAD+, 1 mM; MgSO4, 2mM. For NADH inhibition, the ranges of [NAD+] were: 2.5/iM-1 M for 4-methyl-2-oxopentanoate; 50uM-1 mm for the other two branched-chain 2-oxo acids. The ranges of [CoA] used in the isovalerylCoA inhibition were 2.5-400AM, 37.5-400piM and 3.7-400pM for 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and DL-3-methyl-2-oxopentanoate respectively. The first column shows the oxo acid used (in each case 0.15 mM), and in parentheses the number of rate determinations at each inhibitor concentration. The second column shows the inhibitor and the concentrations (gM) used. K, values are means±S.E.M. genase complex, where the apparent Km for thiamin pyrophosphate decreases with increasing pyruvate concentration (Walsh et al., 1976) . The apparent Km for Mg2+ (measured with MgEDTA buffers) was 4.2,M (see Table 1 ). The Km for thiamin pyrophosphate was dependent on the Mg2+ concentration, being higher at low Mg2+ concentrations (results not shown). This might suggest that thiamin pyrophosphate binding requires Mg2+, as has been demonstrated with pyruvate dehydrogenase (Walsh et al., 1976) . Branched-chain 2-oxo aciddehydrogenase andpyruvate dehydrogenase activities All preparations of branched-chain 2-oxo acid dehydrogenase complex contained pyruvate dehydroVol. -171 genase complex activity, but not 2-oxoglutarate dehydrogenase activity. The Vmax. of the pyruvate dehydrogenase complex in these preparations was less than twice that of the branched-chain 2-oxo acid dehydrogenase activity. However, there is substantial evidence to suggest that the branchedchain 2-oxo acid dehydrogenase activity does not reside in the pyruvate dehydrogenase complex. The oxidation of 52,uM-4-methyl-2-oxo[1-14C]pentanoate by branched-chain 2-oxo acid dehydrogenase complex was not inhibited by the presence of 1.25 mmpyruvate ( Fig. 4 ; see under 'Methods' for radiochemical assay).
2-Oxo acid
Pyruvate dehydrogenase complex purified from ox heart by the method of Linn et al. (1972) did not oxidize any of the three branched-chain 2-oxo acids (assayed spectrophotometrically through NADH formation with mM-NAD+, 0.4mm-CoA, 0.4mM-thiamin pyrophosphate, 2mM-MgSO4 and 0.15mM-branched-chain 2-oxo acid). The limit of detection in these experiments was 2% of the activity with pyruvate. Moreover, the branched-chain 2-oxo acids preparation from ox liver sediments in 20 % (w/v) sucrose at 8.1 x 106g-min. This indicates that the activity is of high molecular weight. In this respect and in the nature of the reaction catalysed, the requirements for substrates and cofactors, and competitive inhibition by isovaleryl-CoA (versus CoA) and by NADH (versus NAD+), it is analogous to pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes. The question as to whether this activity resides in a high-molecular-weight complex containing decarboxylase, dihydrolipoyl acyltransferase and dihydrolipoyl dehydrogenase components can only be resolved by purification and analysis. We shall assume for the purposes of further discussion that the activity is due to such a complex.
The following evidence may indicate that a single complex can catalyse the oxidative decarboxylation of 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutyrate and D-and L-3-methyl-2-oxopentanoates. Fig. 4 shows that the formation of '4CO2 from 4-methyl-2-oxo[1-14C]pentanoate is inhibited by 3-methyl-2-oxobutyrate and DL-3-methyl-2-oxopentanoate (a) at concentrations that produce substrate inhibition and (b) at concentrations below those showing substrate inhibition (see Fig. 1 ). Under the conditions used in Fig. 4 (b) the relative velocities (means ±S.E.M. from linear-regression analyses) were 100 (4-methyl-2-oxopentanoate alone), 16.4±1.8 (with DL-3-methyl-2-oxopentanoate) and 19.5+1.9 (with 3-methyl-2-oxobutyrate). Fig. 5 shows that rates of NADH production with 3-methyl-2-oxobutyrate alone at 10, 20, 40 and 80,um (selected because it has the highest Vmax.) were not increased by the further addition of40,uM-4-methyl-2-oxopentanoate or 40pM-3-methyl-2-oxopentanoate. Ifmore than one dehydrogenase activity were involved in the oxidation of the three 2-oxo acids one might 1978
expect to see evidence of additive rates. No such evidence was obtained (Fig. 5 ). As mentioned above, the oxidation of all three branched-chain 2-oxo acids was inhibited by isovaleryl-CoA (competitive with CoA) and the K1 values were comparable. The observation that the D and L isomers of 3-methyl-2-oxopentanoate are both oxidized also suggests the presence of a dehydrogenase complex of broad specificity. Connelly et al. (1968) and have described the partial purification of branched-chain 2-oxo acid dehydrogenase activities from ox liver. They have concluded that there may be two separate dehydrogenase complexes, one catalysing the oxidation of 4-methyl-2-oxopentanoate and DL-3-methyl-2-oxopentanoate and the other catalysing the oxidation of 3-methyl-2-oxobutyrate. The preparation that we have used is obviously different in its kinetic properties and apparently in its specificity. The Km values for 2-oxo acids given by Connelly et al. (1968) were in the mm range. Our enzyme preparation gave Km values two orders of magnitude less, and moreover showed marked substrate inhibition by 2-oxo acids in the mm range. Our observations regarding substrate specificity and inhibition at high substrate concentration agree with the results of studies on the decarboxylation of branched-chain 2-oxo acids by extracts of rat liver (Wohlhueter & Harper, 1970) .
